Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has evolved as a pivotal enzyme in lipid metabolism and a revolutionary therapeutic target for hypercholesterolemia and its related cardiovascular diseases (CVD). This comprehensive review delineates the intricate roles and wide-ranging implications of PCSK9, extending beyond CVD to emphasize it...
Alternative Titles
Full title
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6181cf680aaa49b0bebe72d6360e60bc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6181cf680aaa49b0bebe72d6360e60bc
Other Identifiers
ISSN
2059-3635,2095-9907
E-ISSN
2059-3635
DOI
10.1038/s41392-023-01690-3
